Frequently Asked Questions
The market is segmented based on Global STD Diagnostics Market, By Type (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing), Testing (Laboratory Devices, Point of Care Devices), Testing Devices (Thermal Cyclers, PCR, Lateral Flow Readers - Immunochromatographic Assays, Flow Cytometers, Differential Light Scattering Machines, Absorbance Microplate Reader, Phone Chips, Rapid Diagnostic Kits), End-User (Hospitals, Others) – Industry Trends and Forecast to 2030.
.
The Global Std Diagnostics Market size was valued at USD 9190.00 USD Million in 2022.
The Global Std Diagnostics Market is projected to grow at a CAGR of 8.7% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, BD, Biocartis, bioMérieux, BioRad Laboratories, Cepheid, Danaher, DiaSorin, GenMark Diagnostics, Hologic , OraSure Technologies, Qualigen , Quidel Corporation, F. Hoffmann La Roche Ltd, Thermo Fisher Scientific , MedMira .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
